AI assistant
Sending…
TuHURA Biosciences, Inc./NV — Director's Dealing 2014
Jan 31, 2014
34026_dirs_2014-01-31_53ccfaf9-7bf0-40e0-9cf1-2a589ac60979.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DelMar Pharmaceuticals, Inc. (DMPI)
CIK: 0001498382
Period of Report: 2014-01-29
Reporting Person: TOTH ROBERT JOSEPH JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-29 | COMMON STOCK | P | 7500 | $.91 | Acquired | 7500 | Direct |
More from TuHURA Biosciences, Inc./NV
Capital/Financing Update
2026
May 29
Interim / Quarterly Report
2026
May 15
Report Publication Announcement
2026
May 15
Capital/Financing Update
2026
Apr 22
Capital/Financing Update
2026
Apr 8
Regulatory Filings
2026
Apr 8
Earnings Release
2026
Apr 1
Director's Dealing
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 17